Brought to you by 
Prestige Brands buys Insight Pharmaceuticals for $750mm cash
05 Sep 2014
Executive Summary
In its largest deal ever, Prestige Brands Holdings Inc. paid $750mm cash to acquire fellow OTC health care products company Insight Pharmaceuticals LLC. After considering tax attributes valued at about $100mm, privately held Insight will get $650mm from Prestige.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Urine-based Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Prestige Brands buys Insight Pharmaceuticals for $750mm cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice